Join to View Full Profile
14511 Old Katy Rd Ste 232Houston, TX 77079
Phone+1 346-933-1146
Dr. Huang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Infectious Disease, 2002 - 2005
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2000 - 2002
McGovern Medical School at UTHealthClass of 2000
Certifications & Licensure
TX State Medical License 2001 - 2026
NY State Medical License 2006 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 1 citationsThe activity of the diaminopyrimidine dihydrofolate reducatase inhibitor, iclaprim, against Toxoplasma gondii in an in vitro model: a pilot study.David B. Huang
Diagnostic Microbiology and Infectious Disease. 2021-04-01 - In vitro activity of iclaprim and comparator agents against Listeria monocytogenes clinical isolates from 2012 to 2018.David B. Huang, Leonard R. Duncan, Yahse K. Edah, Paul R. Rhomberg, Robert K. Flamm
Journal of Global Antimicrobial Resistance. 2021-03-01 - 106 citationsComparison of Newer Intraocular Lens Power Calculation Methods for Eyes after Corneal Refractive SurgeryLi Wang, Maolong Tang, David Huang, Mitchell P. Weikert, Douglas D. Koch
Ophthalmology. 2015-12-01
Authored Content
- A Pooled Analysis of the Phase 3 REVIVE Trials: Randomized, Double-Blind Studies to EValuate the Safety and Efficacy of Iclaprim Versus Vancomycin for trEatment of Acute Bacterial Skin and Skin Structure InfectionsMay 2018
- A Pooled Analysis of the Phase 3 REVIVE Trials: Randomized, Double-Blind Studies to EValuate the Safety and Efficacy of Iclaprim Versus Vancomycin for trEatment of Acute Bacterial Skin and Skin Structure InfectionsMay 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
